BIOMARIN PHARMACEUTICAL INC — Director's Dealing 2012

Dec 21, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK: 0001048477
Period of Report: 2012-12-21

Reporting Person: BIENAIME JEAN JACQUES (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-12-21	Common Stock	M	3000	$12.99	Acquired	170691	Direct
2012-12-21	Common Stock	M	6000	$12.99	Acquired	176691	Direct
2012-12-21	Common Stock	S	3000	$48.5708	Disposed	173691	Direct
2012-12-21	Common Stock	S	6000	$48.5708	Disposed	167691	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-21	Stock Option (right to buy) Common Stock	$12.99	M	3000	Disposed	2016-05-10	Common Stock (3000)	Direct
2012-12-21	Stock Option (right to buy) Common Stock	$12.99	M	6000	Disposed	2016-05-10	Common Stock (6000)	Direct

Footnotes

F1: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on August 10, 2012.

F2: Transaction made pursuant to a Rule 10b5-1 Trading plan executed on March 12, 2012.

F3: The price in Column 4 is a weighted average price. The prices actually received ranged from $48.35 to $48.91. The reporting person will provide to the issue, any security holder of the issuer, or SEC staff, upon request, information regarding the number of shares sold at each price within the range.

F4: Original option grant vests 6/48th on November 11, 2006 and 1/48th on the 11th day of every month thereafter.